Nureca Limited (NURECA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.022x

Based on the latest financial reports, Nureca Limited (NURECA) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs44.46 Million ≈ $480.82K USD) by net assets (Rs1.99 Billion ≈ $21.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nureca Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Nureca Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NURECA current and long-term liabilities for a breakdown of total debt and financial obligations.

Nureca Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nureca Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
BMG Resources Ltd
AU:BMG
-0.022x
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
0.042x
Bowen Acquisition Corp Ordinary Shares
NASDAQ:BOWN
0.000x
Global Vectra Helicorp Limited
NSE:GLOBALVECT
1.675x
Qmines Ltd
AU:QML
-0.083x
Earlypay Ltd
AU:EPY
0.039x
Volitionrx Ltd
NYSE MKT:VNRX
0.097x
GWR Group Ltd
AU:GWR
0.020x

Annual Cash Flow Conversion Efficiency for Nureca Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Nureca Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see NURECA market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs1.94 Billion
≈ $21.01 Million
Rs-190.83 Million
≈ $-2.06 Million
-0.098x -599.40%
2024-03-31 Rs1.93 Billion
≈ $20.88 Million
Rs-27.12 Million
≈ $-293.29K
-0.014x -126.76%
2023-03-31 Rs1.95 Billion
≈ $21.08 Million
Rs102.27 Million
≈ $1.11 Million
0.052x +662.22%
2022-03-31 Rs2.03 Billion
≈ $21.98 Million
Rs13.99 Million
≈ $151.30K
0.007x -96.78%
2021-03-31 Rs1.63 Billion
≈ $17.64 Million
Rs348.67 Million
≈ $3.77 Million
0.214x +140.30%
2020-03-31 Rs149.34 Million
≈ $1.62 Million
Rs-79.23 Million
≈ $-856.84K
-0.531x -1581.51%
2019-03-31 Rs85.45 Million
≈ $924.11K
Rs3.06 Million
≈ $33.09K
0.036x -37.78%
2018-03-31 Rs17.20 Million
≈ $186.01K
Rs990.00K
≈ $10.71K
0.058x +106.30%
2017-03-31 Rs102.45K
≈ $1.11K
Rs-93.62K
≈ $-1.01K
-0.914x --

About Nureca Limited

NSE:NURECA India Medical Devices
Market Cap
$27.50 Million
Rs2.54 Billion INR
Market Cap Rank
#23994 Global
#1327 in India
Share Price
Rs266.51
Change (1 day)
+0.09%
52-Week Range
Rs206.75 - Rs332.62
All Time High
Rs2117.13
About

Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more